Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

被引:4
|
作者
Patlolla, Sri Harsha [1 ]
Schaff, Hartzell V. [1 ]
Nishimura, Rick A. [2 ]
Eleid, Mackram F. [2 ]
Geske, Jeffrey B. [2 ]
Ommen, Steve R. [2 ]
机构
[1] Mayo Clin, Dept Cardiovasc Surg, 200 First Street SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA
来源
关键词
disparities; ethnicity; hypertrophic cardiomyopathy; race; septal reduction; MYECTOMY; ABLATION; VOLUME;
D O I
10.1161/JAHA.122.026661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundInformation on impact of race and ethnicity on use and early outcomes of septal reduction therapies (SRTs) for obstructive hypertrophic obstructive cardiomyopathy are limited. Methods and ResultsUsing the National Inpatient Sample from January 2012 through December 2019, we identified all adult admissions with a primary diagnosis of obstructive hypertrophic cardiomyopathy and those undergoing SRT. Predictors of receiving SRT and outcomes including in-hospital mortality, complications, and resource use were evaluated in racial and ethnic groups. Among a total of 18 895 adult admissions with obstructive hypertrophic cardiomyopathy, SRT was performed in 7255 (38.4%) admissions. Septal myectomy was performed in 4930 (26.1%), while alcohol septal ablation was performed in 2325 (12.3%). In adjusted analysis, Black patient (versus White patient adjusted odds ratio, 0.65 [95% CI, 0.57-0.73]; P<0.001) and Hispanic patient admissions (versus White adjusted odds ratio, 0.78 [95% CI, 0.66-0.92]; P=0.003) were less likely to receive SRT. Among admissions undergoing SRT, in-hospital mortality was significantly higher for Hispanic (adjusted odds ratio, 3.38 [95% CI, 1.81-6.30], P<0.001) and other racial and ethnic groups (adjusted odds ratio 2.02 [95% CI, 1.00-4.11]; P=0.05) compared with White patient admissions, whereas Black patient admissions had comparable mortality. Black, Hispanic, and other ethnic group patients had higher rates of SRT complications and more frequent dismissals to acute care facilities. ConclusionsAmong obstructive hypertrophic cardiomyopathy hospitalizations, minoritized racial groups were less likely to receive SRT. Importantly, hospitalizations of Hispanic and other ethnic patients undergoing SRT had significantly higher in-hospital mortality and complication rates. Further studies with granular echocardiographic information to assess indications for SRT are needed to better understand these differences.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy
    Watkins, H
    McKenna, WJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) : 477 - 479
  • [22] Percutaneous Radiofrequency Septal Reduction for Hypertrophic Obstructive Cardiomyopathy in Children
    Sreeram, Narayanswami
    Emmel, Mathias
    de Giovanni, Joseph V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (24) : 2501 - 2510
  • [23] CYANOACRYLATE FOR NONSURGICAL SEPTAL REDUCTION THERAPY IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Oto, A.
    Aytemir, K.
    Okutucu, S.
    Cil, B.
    Peynircioglu, B.
    Kaya, E. B.
    Deniz, A.
    Evranos, B.
    Sahiner, L.
    Kabakci, G.
    Tokgozoglu, L.
    Ozkutlu, H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S70 - S71
  • [24] Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction
    Desai, Milind Y.
    Owens, Anjali
    Wolski, Kathy
    Geske, Jeffrey B.
    Saberi, Sara
    Wang, Andrew
    Sherrid, Mark
    Cremer, Paul C.
    Lakdawala, Neal K.
    Tower-Rader, Albree
    Fermin, David
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Zhong, Yue
    Wyrwich, Kathleen W.
    Lampl, Kathy L.
    Sehnert, Amy J.
    Nissen, Steven E.
    Spertus, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (11) : 1041 - 1045
  • [25] Induced septal infarction nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy - Response
    Sigwart, U
    CIRCULATION, 1998, 97 (07) : 709 - 709
  • [26] Septal Myectomy Outcomes in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy
    Griffeth, Elaine M.
    Dearani, Joseph A.
    V. Schaff, Hartzell
    Johnson, Jonathan N.
    Ackerman, Michael J.
    Bos, Martijn
    Alzate-Aguirre, Mateo
    Todd, Austin
    Cannon, Bryan C.
    Wackel, Philip L.
    Stephens, Elizabeth H.
    ANNALS OF THORACIC SURGERY, 2023, 116 (03): : 499 - 507
  • [27] Lifetime Costs of Septal Reduction Therapies are Substantially Lower Compared to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy
    Daaboul, Yazan
    Rowin, Ethan
    Maron, Martin
    Kimmelstiel, Carey
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B144 - B144
  • [28] SYSTEMATIC LITERATURE REVIEW OF THE EFFICACY AND SAFETY OF PHARMACOLOGICAL TREATMENTS AND SEPTAL REDUCTION THERAPIES FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    Spoorendonk, J. A.
    Sahbaz Gulser, S.
    Arca, E.
    Hurst, M.
    Zema, C.
    Contente, M.
    Krause, T.
    VALUE IN HEALTH, 2022, 25 (12) : S368 - S368
  • [29] Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy
    Altibi, Ahmed M.
    Ghanem, Fares
    Zhao, Yuanzi
    Elman, Miriam
    Cigarroa, Joaquin
    Nazer, Babak
    Song, Howard K.
    Masri, Ahmad
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [30] HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - THE USE OF A DIATHERMY LOOP FOR SEPTAL RESECTION
    ARMISTEAD, SH
    WILLIAMS, BT
    JOURNAL OF CARDIOVASCULAR SURGERY, 1984, 25 (02): : 185 - 186